Latest updates from EMA in response to the COVID-19 pandemic.
Articles filtered by tag
The EU Pilot for 2 Member States to gain simultaneous national scientific advice is launched on 1st February. Find out more here.
Two Months to Go – Human medicinal product licences to be reviewed for the presence of Nitrosamine Impurities
Nitrosamines, TOPRA, & Drug Development News are the focus for our Q4 Industry Insights
Global Harmonisation of Clinical Trials is the latest focus for our quarterly roundup of the regulatory landscape with news from EMA, FDA and ICH
Our latest Industry Insights focuses on Brexit and news from the regulators around the globe.
Part Two of the report from the SME Day at the EMA focuses on Marketing Authorisations and more.
Larissa Gould reports from the EMA in Canary Wharf on the latest developments.
Our latest industry update covers news about Brexit, from FDA, EMA and more.
Our staff and events teams are working hard, as we head towards the end of the year.
Stephen Thompson, our regulatory affairs Director, writes about the latest Brexit news.